Comparison of 68Ga-FAPI and 18F-DOPA PET/CT in patients with medullary thyroid cancer - Takeaways - MDSpire

Comparison of 68Ga-FAPI and 18F-DOPA PET/CT in patients with medullary thyroid cancer

  • By

  • Daniel A. Hescheler

  • Dogan Atiyat

  • Kerstin Lorenz

  • Alexander Heinzel

  • Philipp Reschke

  • Frankis G. Almaguel

  • Manuela Petersen

  • Elisabeth Eppard

  • Joanna Wybranska

  • Jan Wuestemann

  • Michael C. Kreissl

  • June 24, 2026

  • 0 min

Share

  • 1

    This study compared 68Ga-FAPI PET/CT with 18F-DOPA PET/CT for detecting metastases in medullary thyroid carcinoma patients.

  • 2

    Nine patients with a mean age of 55 years and 62 lesions were analyzed in this retrospective study.

  • 3

    68Ga-FAPI demonstrated significantly higher detection rates for lymph node, lung, and liver metastases compared to 18F-DOPA.

  • 4

    The true-positive rates for lymph node, lung, and liver metastases were 100%, 85.7%, and 100% for 68Ga-FAPI, respectively.

  • 5

    68Ga-FAPI PET/CT showed higher tumor-to-background ratios than 18F-DOPA, indicating improved imaging potential for MTC.

Original Source(s)

Related Content